INKT
MiNK Therapeutics·NASDAQ
--
--(--)
--
--(--)
INKT fundamentals
MiNK Therapeutics (INKT) released its earnings on Nov 14, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.65 (YoY -1200.00%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.65
-1200.00%
Report date
Nov 14, 2025
INKT Earnings Call Summary for Q3,2025
- Clinical Milestone: agenT-797 achieves 23-month median OS in refractory solid tumors, exceeding historical benchmarks by 383%.
- Strategic Expansion: $15.5M+ cash runway through 2026, supporting global Phase II/III pulmonary trial and GvHD study.
- Manufacturing Strength: 1B cells/donor yield enables cost-efficient stockpiling, with 3-year shelf life for iNKT cells.
- Partnership Power: Federal grants and academic collaborations reduce capital intensity by 70%+ for late-stage programs.
EPS
Revenue
Revenue & Expenses
Key Indicators
MiNK Therapeutics (INKT) key financial stats and ratios, covering profitability, financial health, and leverage.
MiNK Therapeutics (INKT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
MiNK Therapeutics (INKT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
MiNK Therapeutics (INKT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does MiNK Therapeutics (INKT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track MiNK Therapeutics (INKT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is MiNK Therapeutics's latest dividend and current dividend yield?What factors drove the changes in MiNK Therapeutics's revenue and profit?What were the key takeaways from MiNK Therapeutics's earnings call?What were the key takeaways from MiNK Therapeutics’s earnings call?What guidance did MiNK Therapeutics's management provide for the next earnings period?What is MiNK Therapeutics's gross profit margin?What is the market's earnings forecast for MiNK Therapeutics next quarter?What does MiNK Therapeutics do and what are its main business segments?
